Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab

Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity

Helen A. Mintz-Hittner, Kathleen A. Kennedy, Alice Z. Chuang · New England Journal of Medicine · 2011 · 1.4K citations · Full text

The International Classification of Retinopathy of Prematurity Revisited : An International Committee for the Classification of Retinopathy of Prematurity

Glen A. Gole, Anna L. Ells, Ximena Katz et al. · Archives of Ophthalmology · 2005 · 1.4K citations

Ocular Disease, International Committee, Ophthalmology +7

Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration

Usha Chakravarthy, Simon Harding, Chris Rogers et al. · Ophthalmology · 2012 · 771 citations

Ranibizumab Versus Bevacizumab, Ocular Disease, Ophthalmology +3

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology

MA Forbes, SE Kinsey, Arthur Stanley et al. · British Journal of Cancer · 1998 · 605 citations · Full text

Thrombopoiesis, Thrombosis, Angiogenesis +11

Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration

Jacques Gaudreault, David Fei, Jeriza Rusit et al. · Investigative Ophthalmology & Visual Science · 2005 · 501 citations